Drug Search Results

CLB-3000

Alternative Names: CLB-3000, CLB3000, CLB 3000
Latest Update: 2024-08-11
Latest Update Note: Clinical Trial Update

Product Description

CLB-3000 is a therapeutic vaccine designed to drive functional cure of hepatitis B. (Sourced from: https://clearbtherapeutics.com/clearb-therapeutics-announces-acceptance-of-abstract-highlighting-pre-clinical-chronic-hepatitis-b-data-as-a-poster-presentation-at-easl-2022/)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: ClearB Therapeutics
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for CLB-3000

Countries in Clinic: Australia

Active Clinical Trial Count: 1

Highest Development Phases

Phase 1: Hepatitis B, Chronic|Intestinal Diseases

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
ACTRN12623000841673	P1	Active, not recruiting	Intestinal Diseases\|Hepatitis B, Chronic	2024-03-22

Recent News Events

Date	Type	Title
05/29/2024	News Article	ClearB Therapeutics Announces Upcoming Poster Presentations of Pre-Clinical Chronic Hepatitis B Data at EASL 2024
10/12/2023	News Article	ClearB Therapeutics Announces First Patient Dosed in a Phase 1b
06/20/2023	News Article	ClearB Therapeutics Announces Upcoming Poster Presentations of Pre-Clinical Chronic Hepatitis B Data at EASL 2023
10/24/2022	News Article	ClearB Therapeutics Announces Upcoming Poster Presentations of Pre-Clinical Hepatitis B Data at AASLD 2022

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions